Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — September 2020

Planlagt Fastgjort Låst Flyttet Genmab
1.0k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • G Offline
    G Offline
    GeorgeBest
    wrote on sidst redigeret af
    #941

    Efficacy of daratumumab in the treatment of multiple myeloma with high-risk cytogenetics: Meta-analysis of randomized phase III trials https://twitter.com/mtmdphd/status/1309129398990385153?s=21

    1 Reply Last reply
    0
    • Helge_LarsenPI-redaktørH Offline
      Helge_LarsenPI-redaktørH Offline
      Helge_LarsenPI-redaktør
      wrote on sidst redigeret af
      #942

      God morgen. 🙂

      1 Reply Last reply
      0
      • E Offline
        E Offline
        E_L
        wrote on sidst redigeret af
        #943

        Daratumumab (anti-CD38) for treatment of disseminated nontuberculous mycobacteria in a patient with anti-IFN-γ autoantibodies https://academic.oup.com/cid/advance-article/doi/10.1093/cid/ciaa1086/5880009

        1 Reply Last reply
        0
        • E Offline
          E Offline
          E_L
          wrote on sidst redigeret af
          #944

          now, i read about Covid-19 and anti-IFN-γ autoantibodies, but it is probably a bit farfetched to make a Dara - Covid link 😉

          1 Reply Last reply
          0
          • T Offline
            T Offline
            transalp
            wrote on sidst redigeret af
            #945

            Go morgen.. 🙂

            1 Reply Last reply
            0
            • B Offline
              B Offline
              bibob
              wrote on sidst redigeret af
              #946

              God morgen. 🙂

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #947

                I noted Genmab is looking for an Infectious Diseases Scientist and that there is something called "Genmab Infectious Disease initiative" https://genmab.wd3.myworkdayjobs.com/en-US/Genmab_Careers_Site/job/Utrecht/Scientist--Infectious-Diseases_R414

                1 Reply Last reply
                0
                • B Offline
                  B Offline
                  bibob
                  wrote on sidst redigeret af
                  #948

                  Nice E L. New field for Genmab isn't it. ??

                  1 Reply Last reply
                  0
                  • E Offline
                    E Offline
                    E_L
                    wrote on sidst redigeret af
                    #949

                    they had a partnership with a small Danish company looooong time ago in infectious diseases, not even sure if that company still exists lol

                    1 Reply Last reply
                    0
                    • P Offline
                      P Offline
                      peter12
                      wrote on sidst redigeret af
                      #950

                      ACE Biosciences acc to google. Genmab mention infectious disease when describing Duobody platform. Did they cooperate with Amgen about something similar ?

                      1 Reply Last reply
                      0
                      • G Offline
                        G Offline
                        gentogen
                        wrote on sidst redigeret af
                        #951

                        Faldt lidt tilfældigt over denne gamle nyhed, som jeg ikke havde hørt om før: Tavotek Biotherapeutics Announces a Research Agreement with Genmab for the Development of Bispecific Antibodies using Genmab’s Proprietary DuoBody® Technology Platform against a Pair of Disease Relevant Targets

                        1 Reply Last reply
                        0
                        • G Offline
                          G Offline
                          gentogen
                          wrote on sidst redigeret af
                          #952

                          Link Preview Image
                          Tavotek Announces a Research Agreement with Genmab for the Development of Bispecific Antibodies using Genmab's DuoBody® Platform against a Pair of Disease Relevant Targets

                          /PRNewswire/ -- Tavotek Biotherapeutics, a biotech company which develops novel biologics for autoimmune diseases and oncology, announced that it has entered...

                          favicon

                          (www.prnewswire.com)

                          1 Reply Last reply
                          0
                          • P Offline
                            P Offline
                            peter12
                            wrote on sidst redigeret af
                            #953

                            Den har været nævnt her før men lyder spændende

                            1 Reply Last reply
                            0
                            • P Offline
                              P Offline
                              Plimsoller
                              wrote on sidst redigeret af
                              #954

                              God morgen 🙂

                              1 Reply Last reply
                              0
                              • Helge_LarsenPI-redaktørH Offline
                                Helge_LarsenPI-redaktørH Offline
                                Helge_LarsenPI-redaktør
                                wrote on sidst redigeret af
                                #955

                                God morgen. 🙂

                                1 Reply Last reply
                                0
                                • M Offline
                                  M Offline
                                  Mogan
                                  wrote on sidst redigeret af
                                  #956

                                  God morgen 🙂

                                  1 Reply Last reply
                                  0
                                  • S Offline
                                    S Offline
                                    Stroka
                                    wrote on sidst redigeret af
                                    #957

                                    Ikke megen chat i dag. Kursen klarer sig heldigvis fint uden. 🙂

                                    1 Reply Last reply
                                    0
                                    • Helge_LarsenPI-redaktørH Offline
                                      Helge_LarsenPI-redaktørH Offline
                                      Helge_LarsenPI-redaktør
                                      wrote on sidst redigeret af
                                      #958

                                      DAX går pænt amok: https://www.proinvestor.com/investornyt/667649/dax-future-brager-op-gennem-12800-nu-3-i-dag

                                      1 Reply Last reply
                                      0
                                      • E Offline
                                        E Offline
                                        E_L
                                        wrote on sidst redigeret af
                                        #959

                                        Large new ECOG-ACRIN trial, Dara Len Dex, adding Bortezomib in the consolidation phase only https://clinicaltrials.gov/ct2/show/NCT04566328?term=genmab+OR+daratumumab+OR+darzalex+OR+ofatumumab+OR+Teprotumumab+OR+Tisotumab+OR+camidanlumab+OR+Enapotamab+OR+ADCT-301+OR+duobody&lupd_s=09%2F28%2F2020&draw=2&rank=3

                                        1 Reply Last reply
                                        0
                                        • S Offline
                                          S Offline
                                          Sukkeralf
                                          wrote on sidst redigeret af
                                          #960

                                          A third wing of the biotech is working on protein-based therapies, including in programs that pair its technology with the potentially complementary capabilities of CRISPR Therapeutics and Genmab.

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger